Cargando…

Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays

Deficiency of dihydropyrimidine dehydrogenase (DPD), encoded by the DPYD gene, is associated with severe toxicity induced by the anti-cancer drug 5-Fluorouracil (5-FU). DPYD genotyping of four recommended polymorphisms is widely used to predict toxicity, yet their prediction power is limited. Increa...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Ottavia, Salerno, Gerardo, De Bernardini, Donatella, Torre, Maria Simona, Simmaco, Maurizio, Lionetto, Luana, Gentile, Giovanna, Borro, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694733/
https://www.ncbi.nlm.nih.gov/pubmed/36430399
http://dx.doi.org/10.3390/ijms232213923
_version_ 1784837878084272128
author De Luca, Ottavia
Salerno, Gerardo
De Bernardini, Donatella
Torre, Maria Simona
Simmaco, Maurizio
Lionetto, Luana
Gentile, Giovanna
Borro, Marina
author_facet De Luca, Ottavia
Salerno, Gerardo
De Bernardini, Donatella
Torre, Maria Simona
Simmaco, Maurizio
Lionetto, Luana
Gentile, Giovanna
Borro, Marina
author_sort De Luca, Ottavia
collection PubMed
description Deficiency of dihydropyrimidine dehydrogenase (DPD), encoded by the DPYD gene, is associated with severe toxicity induced by the anti-cancer drug 5-Fluorouracil (5-FU). DPYD genotyping of four recommended polymorphisms is widely used to predict toxicity, yet their prediction power is limited. Increasing availability of next generation sequencing (NGS) will allow us to screen rare variants, predicting a larger fraction of DPD deficiencies. Genotype–phenotype correlations were investigated by performing DPYD exon sequencing in 94 patients assessed for DPD deficiency by the 5-FU degradation rate (5-FUDR) assay. Association of common variants with 5-FUDR was analyzed with the SNPStats software. Functional interpretation of rare variants was performed by in-silico analysis (using the HSF system and PredictSNP) and literature review. A total of 23 rare variants and 8 common variants were detected. Among common variants, a significant association was found between homozygosity for the rs72728438 (c.1974+75A>G) and decreased 5-FUDR. Haplotype analysis did not detect significant associations with 5-FUDR. Overall, in our sample cohort, NGS exon sequencing allowed us to explain 42.5% of the total DPD deficiencies. NGS sharply improves prediction of DPD deficiencies, yet a broader collection of genotype–phenotype association data is needed to enable the clinical use of sequencing data.
format Online
Article
Text
id pubmed-9694733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96947332022-11-26 Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays De Luca, Ottavia Salerno, Gerardo De Bernardini, Donatella Torre, Maria Simona Simmaco, Maurizio Lionetto, Luana Gentile, Giovanna Borro, Marina Int J Mol Sci Article Deficiency of dihydropyrimidine dehydrogenase (DPD), encoded by the DPYD gene, is associated with severe toxicity induced by the anti-cancer drug 5-Fluorouracil (5-FU). DPYD genotyping of four recommended polymorphisms is widely used to predict toxicity, yet their prediction power is limited. Increasing availability of next generation sequencing (NGS) will allow us to screen rare variants, predicting a larger fraction of DPD deficiencies. Genotype–phenotype correlations were investigated by performing DPYD exon sequencing in 94 patients assessed for DPD deficiency by the 5-FU degradation rate (5-FUDR) assay. Association of common variants with 5-FUDR was analyzed with the SNPStats software. Functional interpretation of rare variants was performed by in-silico analysis (using the HSF system and PredictSNP) and literature review. A total of 23 rare variants and 8 common variants were detected. Among common variants, a significant association was found between homozygosity for the rs72728438 (c.1974+75A>G) and decreased 5-FUDR. Haplotype analysis did not detect significant associations with 5-FUDR. Overall, in our sample cohort, NGS exon sequencing allowed us to explain 42.5% of the total DPD deficiencies. NGS sharply improves prediction of DPD deficiencies, yet a broader collection of genotype–phenotype association data is needed to enable the clinical use of sequencing data. MDPI 2022-11-11 /pmc/articles/PMC9694733/ /pubmed/36430399 http://dx.doi.org/10.3390/ijms232213923 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
De Luca, Ottavia
Salerno, Gerardo
De Bernardini, Donatella
Torre, Maria Simona
Simmaco, Maurizio
Lionetto, Luana
Gentile, Giovanna
Borro, Marina
Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
title Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
title_full Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
title_fullStr Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
title_full_unstemmed Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
title_short Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays
title_sort predicting dihydropyrimidine dehydrogenase deficiency and related 5-fluorouracil toxicity: opportunities and challenges of dpyd exon sequencing and the role of phenotyping assays
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694733/
https://www.ncbi.nlm.nih.gov/pubmed/36430399
http://dx.doi.org/10.3390/ijms232213923
work_keys_str_mv AT delucaottavia predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays
AT salernogerardo predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays
AT debernardinidonatella predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays
AT torremariasimona predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays
AT simmacomaurizio predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays
AT lionettoluana predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays
AT gentilegiovanna predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays
AT borromarina predictingdihydropyrimidinedehydrogenasedeficiencyandrelated5fluorouraciltoxicityopportunitiesandchallengesofdpydexonsequencingandtheroleofphenotypingassays